FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2431284291> ?p ?o ?g. }

• W2431284291 abstract "Mild, temporary hepatic failure (MTHF) after chemotherapy is a common clinical problem; in case of repeated episodes MTHF may cause chronic impairment. This registry has evaluated post- chemotherapy (PC)-MTHF in subjects using Liverubin (standardized Silymarin) for 8 weeks (3 capsules/day). PC-MTHF was evaluated in a registry study. Hepatitis markers were negative at inclusion and at end-registry. In the final registry there were results concerning 18 Liverubin-supplemented patients and 19 controls completing the 8-week period. Signs/symptoms. The distribution of the most common symptoms and signs with ultrasound scans were comparable. Symptoms were mostly minimal or subclinical. Most symptoms observed at inclusion were completely disappeared or greatly attenuated after 8 weeks. The improvement produced by Liverubin induced a better and faster disappearance of symptoms. The results of the blood tests (at inclusion and at 8 weeks showed the increase in albumin, significantly (P<0.05) faster with the final values higher in the supplement group. Total bilirubin was reduced with the supplement better than in controls (P<0.05). Direct bilirubin values improved more in the supplement (P<0.05) group. The decrease in SGPT and AST-ASAT was more evident with the supplement (P<0.05). Improvement in controls was more limited. Alkaline phosphatase was significantly lower (than in controls) with Liverubin at 8 weeks (p<0.05). Gamma GT also decreased more and faster with the supplement. The ESR (erythrocytes sedimentation rate) was decreased in both groups, more in the Liverubin group (P<0.05). There was a more limited decrease in controls with persisting higher values at 8 weeks. The white cell count was also better at 3 months (with a larger decrease with the supplement; P<0.05). Oxidative stress. Plasma free radicals (PFR) were elevated in both groups at inclusion. A more significant decrease in the supplement group was observed at 8 weeks. Persisting elevation in values was seen in controls (P<0.05). Platelets values improved better with Liverubin (P<0.05). Safety and tolerability were optimal (no side effect was registered). In conclusion, results from this pilot registry indicate a significant activity of Liverubin associated with a very good safety profile, in patients with post-chemotherapy hepatic failure. The recovery of hepatic function is faster and more effective with Liverubin in comparison with the best standard management." @default.
• W2431284291 created "2016-06-24" @default.
• W2431284291 creator A5007743014 @default.
• W2431284291 creator A5008403575 @default.
• W2431284291 creator A5013224103 @default.
• W2431284291 creator A5023601750 @default.
• W2431284291 creator A5024392515 @default.
• W2431284291 creator A5032439447 @default.
• W2431284291 creator A5063073558 @default.
• W2431284291 creator A5064539408 @default.
• W2431284291 creator A5078107899 @default.
• W2431284291 creator A5081342232 @default.
• W2431284291 date "2015-10-22" @default.
• W2431284291 modified "2023-09-25" @default.
• W2431284291 title "Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin)." @default.
• W2431284291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26492585" @default.
• W2431284291 hasPublicationYear "2015" @default.
• W2431284291 type Work @default.
• W2431284291 sameAs 2431284291 @default.
• W2431284291 citedByCount "0" @default.
• W2431284291 crossrefType "journal-article" @default.
• W2431284291 hasAuthorship W2431284291A5007743014 @default.
• W2431284291 hasAuthorship W2431284291A5008403575 @default.
• W2431284291 hasAuthorship W2431284291A5013224103 @default.
• W2431284291 hasAuthorship W2431284291A5023601750 @default.
• W2431284291 hasAuthorship W2431284291A5024392515 @default.
• W2431284291 hasAuthorship W2431284291A5032439447 @default.
• W2431284291 hasAuthorship W2431284291A5063073558 @default.
• W2431284291 hasAuthorship W2431284291A5064539408 @default.
• W2431284291 hasAuthorship W2431284291A5078107899 @default.
• W2431284291 hasAuthorship W2431284291A5081342232 @default.
• W2431284291 hasConcept C113280763 @default.
• W2431284291 hasConcept C126322002 @default.
• W2431284291 hasConcept C141071460 @default.
• W2431284291 hasConcept C160160445 @default.
• W2431284291 hasConcept C181199279 @default.
• W2431284291 hasConcept C185592680 @default.
• W2431284291 hasConcept C2776125364 @default.
• W2431284291 hasConcept C2776694085 @default.
• W2431284291 hasConcept C2777513400 @default.
• W2431284291 hasConcept C55493867 @default.
• W2431284291 hasConcept C71924100 @default.
• W2431284291 hasConcept C90924648 @default.
• W2431284291 hasConceptScore W2431284291C113280763 @default.
• W2431284291 hasConceptScore W2431284291C126322002 @default.
• W2431284291 hasConceptScore W2431284291C141071460 @default.
• W2431284291 hasConceptScore W2431284291C160160445 @default.
• W2431284291 hasConceptScore W2431284291C181199279 @default.
• W2431284291 hasConceptScore W2431284291C185592680 @default.
• W2431284291 hasConceptScore W2431284291C2776125364 @default.
• W2431284291 hasConceptScore W2431284291C2776694085 @default.
• W2431284291 hasConceptScore W2431284291C2777513400 @default.
• W2431284291 hasConceptScore W2431284291C55493867 @default.
• W2431284291 hasConceptScore W2431284291C71924100 @default.
• W2431284291 hasConceptScore W2431284291C90924648 @default.
• W2431284291 hasLocation W24312842911 @default.
• W2431284291 hasOpenAccess W2431284291 @default.
• W2431284291 hasPrimaryLocation W24312842911 @default.
• W2431284291 hasRelatedWork W1898786079 @default.
• W2431284291 hasRelatedWork W2024782631 @default.
• W2431284291 hasRelatedWork W2032669931 @default.
• W2431284291 hasRelatedWork W2361606723 @default.
• W2431284291 hasRelatedWork W2416809827 @default.
• W2431284291 hasRelatedWork W2470644515 @default.
• W2431284291 hasRelatedWork W2914652968 @default.
• W2431284291 hasRelatedWork W3022664749 @default.
• W2431284291 hasRelatedWork W4229372840 @default.
• W2431284291 hasRelatedWork W1535489564 @default.
• W2431284291 isParatext "false" @default.
• W2431284291 isRetracted "false" @default.
• W2431284291 magId "2431284291" @default.
• W2431284291 workType "article" @default.